Tags

Type your tag names separated by a space and hit enter

Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.
Autism. 2014 Aug; 18(6):631-7.A

Abstract

This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000-2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes.

Authors+Show Affiliations

The Pennsylvania State University, USA jschubart@hmc.psu.edu.The Pennsylvania State University, USA.The Pennsylvania State University, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24165274

Citation

Schubart, Jane R., et al. "Psychotropic Medication Trends Among Children and Adolescents With Autism Spectrum Disorder in the Medicaid Program." Autism : the International Journal of Research and Practice, vol. 18, no. 6, 2014, pp. 631-7.
Schubart JR, Camacho F, Leslie D. Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. Autism. 2014;18(6):631-7.
Schubart, J. R., Camacho, F., & Leslie, D. (2014). Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. Autism : the International Journal of Research and Practice, 18(6), 631-7. https://doi.org/10.1177/1362361313497537
Schubart JR, Camacho F, Leslie D. Psychotropic Medication Trends Among Children and Adolescents With Autism Spectrum Disorder in the Medicaid Program. Autism. 2014;18(6):631-7. PubMed PMID: 24165274.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program. AU - Schubart,Jane R, AU - Camacho,Fabian, AU - Leslie,Douglas, Y1 - 2013/10/28/ PY - 2013/10/30/entrez PY - 2013/10/30/pubmed PY - 2015/11/5/medline KW - Medicaid KW - autism spectrum disorder KW - children and adolescents KW - psychotropic medications SP - 631 EP - 7 JF - Autism : the international journal of research and practice JO - Autism VL - 18 IS - 6 N2 - This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000-2003). The data set included nearly 3 million children and adolescents who were 17 years or younger. Approximately, 65% of children with autism spectrum disorder received a psychotropic medication. The results indicate an increasing overall trend in the use of psychotropic drugs among children and adolescents with autism spectrum disorders. Among the different classes of psychotropic drugs, antipsychotics were the most common. Increasing trends in polypharmacy were observed both within and between medication classes. SN - 1461-7005 UR - https://www.unboundmedicine.com/medline/citation/24165274/Psychotropic_medication_trends_among_children_and_adolescents_with_autism_spectrum_disorder_in_the_Medicaid_program_ L2 - https://journals.sagepub.com/doi/10.1177/1362361313497537?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -